Patent · US Active

Method for use of homopiperazinium compounds in the treatment of cancer

US9949984B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2015
Grant dateApr 24, 2018
Priority date
Expiry dateApr 1, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating cancer comprising administering to a patient in need thereof an effective amount of a compound having the formula:wherein R1 and R2 are independently alkyl of 1 to 6 carbon atoms or cycloalkyl of 3 to 6 carbon atoms, Xa is CH or N, Ya is hydrogen or a substituent, each of which is independently selected; n is an integer from 1 to 5, J is a counter ion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.